InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Nolet Chris. Director active across 3 companies, notably Revance Therapeutics, Inc.. In total, 8 disclosures have been published. Activity tracked since 5 May 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nolet Chris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
28,606 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015339:0
15,000 shares0Common StockSEC:0001479290-24-000088:0
3,534 shares0Common StockSEC:0001479290-23-000062:0
36,497 shares0Common StockSEC:0001493152-23-001628:0
32,500 shares0Voting Common StockSEC:0001213900-22-063938:0
50,900 shares0Common StockSEC:0001493152-22-027578:0
6,059 shares0Common StockSEC:0001479290-22-000063:0
4,013 shares0Common StockSEC:0001479290-21-000112:0
8 of 8 declarations
About Nolet Chris
Nolet Chris is a declarant and serves as Director at Revance Therapeutics, Inc., POLARITYTE, INC. and Jasper Therapeutics, Inc. The record covers 9 filings in total, all within the recent sample, from 2021-05-07 to 2025-02-06. The modal transaction nature is Attribution, and the buy and sell amounts shown for this sample are 0 and 0; among the top filings is a 2025-02-06 filing at Revance Therapeutics, Inc. for EUR 101102.036576322.
